Excipient Development at NCL

Similar documents
Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications

USP Hypromellose Phthalate

METHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Model-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017

Approaches to the formulation of poorly soluble drugs

Design and Dosage Form. Dr. Deny Susanti

"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY

Kollidon SR: A polyvinyl acetate based excipient for DCsustained-release

Recent FDA Guidance For Industry; BCS Class 1 and 3 August 2015

SUSTAINED RELEASE From Coated Ion Exchange Resins. H.S. Hall Coating Place, Inc. Verona, WI 53593

Dow Pharma Solutions. ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient.

Eudragit. Setting benchmarks in oral solid dosage forms since 1954.

Formulation and in vitro evaluation of bosentan osmatic controlled release tablets

How to Identify Critical Quality Attributes and Critical Process Parameters

Improving Oral Bioavailability by Solid Dispersions: An OSPHENA (Ospemifene) Case Study

THE PHARMA INNOVATION - JOURNAL Formulation and Development of Floating and Mucoadhesive Microspheres of Clarithromycin

The Emerging Technology Program: FDA s Perspective

Development of paediatric formulations - points to consider

Preface... iii Contents...vii Contributors...xv. 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion...

NISSO HPC for Pharmaceutical Applications

Solid dispersions as a formulation strategy for poorly soluble compounds. G. Van den Mooter University of Leuven, Belgium

RapidFACT: Accelerated Formulation Development for Poorly Soluble Drugs and Modified Release Products

Formulation Development of New Chemical Entities (NCEs) Dr. Mariella Artusi Pharmaceutical Development Dept. Monza

Formulation Design and Optimization of an Enteric Coated Sustained Release Mucoadhesive Tablet of Metronidazole

INTERPHEX USA 80-1 ROUTINE EVALUATION OF FILM COATING PROCESSES. M. Talei, Pharm.D., Ph.D. ALZA Corporation Palo Alto, CA INTRODUCTION

Solution Vinyl Resin

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up

Roles And Applications of Cellulose Ether in Environmentally Friendly. Building Materials

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Preparation of Ethylcellulose Coated Gelatin Microspheres as a Multiparticulate Colonic Delivery System for 5-Aminosalicilic Acid

Preparation of Ethylcellulose Coated Gelatin Microspheres as a Multiparticulate Colonic Delivery System for 5-Aminosalicilic Acid

A practical computational tool to predict formulation and process variables during the development of spray-dried amorphous solid dispersions.

integrity and improved efficiency

Preparation of Cefpodoxime Proxetil - Polymeric Microspheres by the Emulsion Solvent Diffusion Method for taste masking

CARBOXYMETHYL CELLULOSE NANOCOMPOSITES

* Current monograph name valid until May 1, 2017 ** New monograph name valid as of May 1, 2012, mandatory as of May 1, 2017

Supplementary Material for Chitin and chitosan dissolving. in ionic liquids as reversible sorbents of CO 2

CHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE

Implementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development. S Betterman 15Apr2015

One-Step Aqueous Enteric Coating Systems: Scale-Up Evaluation

Jingkun: providing you with innovative Guar products for Construction Application

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ION EXCHANGE RESIN AS AN IMPOSING METHOD FOR TASTE MASKING: A REVIEW

Biowaiver Approaches for Generic Drug Products in the US: Case Studies

BRITISH BIOMEDICAL BULLETIN

Caffeine 100 mg, Scopolamine Hydrobromide 0.5 mg Oral Rapid-Dissolve Tablets (Solid Suspension, 96 x 750 mg [0.93 ml] Tablets)

Design and Evaluation of a new Capsule-type Dosage form for Colon-Targeted Delivery of Etoricoxib

Abstract. Technical Aspects. Applying GastroPlus for Extensions of Biowaivers for BCS Class II Compounds 2

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

Characterization of Cellulose Acetate Films: Formulation Effects on the Thermomechanical Properties and Permeability of Free Films and Coating Films

Rajesh Kaza. et al /J. Pharm. Sci. & Res. Vol.1(4), 2009,

BCS Guidance and Biowaivers BCS Monographs

In vitro in vivo correlations (IVIVC) can be summarized

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

DOW AMBERLITE and DUOLITE Ion Exchange Resin Excipients

Multiparticulate Drug Delivery Systems for Controlled Release

DIRECTLY COMPRESSIBLE MEDICATED CHEWING GUM (MCG) FOR STAYING ALERT

Pharma Ingredients & Services. Ludiflash. Technical Information

Formulation and In-Vitro Evaluation of Sustained Release Tablet of Isosorbide -5- Mononitrate by Porous Osmotic Technology

Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action

Formulation, Evaluation and Optimization of Fast dissolving tablet containing Tizanidine Hydrochloride

ANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS

Computation of Solubility parameters using Molecular. dynamics simulation

Safety Qualification Process and Application of Thresholds. Jim Blanchard PQRI L&E Toxicology Subgroup Principal Scientist Aradigm

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE:

Quality by Design for ANDAs: An Example for Immediate-Release Dosage Forms

Testosterone 20 mg Oral Rapid-Dissolve Tablets (Solid Suspension, 96 x 750 mg [0.93 ml] Tablets) Ingredient Listing Qty. Unit NDC # Supplier

Public Assessment Report. Scientific discussion. Atovaquon/Proguanil HCl Sandoz 62.5/25 mg and 250/100 mg, film-coated tablets

Abstract Process Economics Program Report 194A SUPERABSORBENT POLYMERS (April 2002)

QbD implementation in Generic Industry: Overview and Case-Study

Taste Masking of Clarithromycin using Complexation with Ion exchange resin

metallic stearates (metal salts/soaps)

Biowaivers and Harmonization Guidelines for Class I and 3 Drugs: Biowaiver Case Studies

Fluoropolymers in Healthcare

OSDrC OptiDose : A Revolution in Drug Formulation Technology

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients

Pharma Silica Insights

Appendices! Product quality documents. Technical guidelines. (Translation from Original Chinese Version)

PLGA Nanoparticles. Production and In Situ Drug Loading Using the NanoAssemblr Benchtop Instrument and the Impact of Solvent Removal Methods.

GUIDELINE FOR THE STABILITY TESTING

Direct compression of cushion layered ethyl cellulose coated extended release pellets into rapidly disintegrating tablets

Polyvinylpyrrolidone Excipients for Pharmaceuticals

Product Data Sheet. Crosslinker CX-100

Effect of Hydrophobic Polymers on the Gastro Retention Time and In vitro Release of Ciprofloxacin HCl from Co-matrix Tablets

International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW

Pelagia Research Library

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.

Influence of Solvents on the Crystal Habit and Properties of Rofecoxib

How do drugs work? Part 1. PK: Principles & Processes. PK vs. PD. Pharmacokinetics : Basic Principles Overview. What does the body do to a drug?

Shashank Tiwari et al /J. Pharm. Sci. & Res. Vol.3(10), 2011,

MATERIAL SAFETY DATA SHEET

Int. J. Pharm. Sci. Rev. Res., 34(1), September October 2015; Article No. 23, Pages: Process Validation of Tablet Dosage Form in Industries

Drug exhibiting absorption from only a. Design and Clinical Evaluation of Floating Mini Matrix Tablets of Pyridoxine Hydrochloride ORIGINAL ARTICLE

Outline. Opportunities Overview of ASAP Areas of Application ASAP Proposal to Regulators Summary

Investigating Differences in Solubility Between Crystalline and Amorphous Forms of Pharmaceuticals

R R Innovation Way P/N SECKIT-7830 Newark, DE 19711, USA Tel: Fax: Website: Published in November 2013

Extractables and leachables: An Introduction

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

RHOPLEX WL-100 Emulsion Copolymer For High-Gloss Plastic Coatings With Excellent Adhesion

Product Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex

Transcription:

New Reverse Enteric Polymer for Oral Dosage Forms Excipient Development at omplete Solution for Taste Masking Moisture Barrier Sustained Release Immediate Release Polymorphism Inhibition National hemical Laboratory, Pune India 1 National hemical Laboratory, Pune India 1

NREP New Reverse Enteric Polymer Product Description NREP is a cationic ter-polymer, responsive to changes in ph. It dissolves at acidic ph < 3.5 and is insoluble and impervious at ph > 4. It is hydrophobic and insoluble in water. The polymer can be used for taste masking where the drug leaching is prevented at ph of saliva and also in aqueous media in case of liquid orals. The polymer can also be used as functional film coating for moisture barrier /sealant properties, immediate release applications and blends of NREP can be used for custom release profiles. Structure of NREP H 2 H 3 O H 3 O H 2 H 3 O O 2 H 4 OH New Reverse Enteric Polymer H 2 NREP is a random terpolymer based on methyl methacrylate, 2-hydroxy ethyl methacrylate and 4-vinylpyridine. It is a selfassociated acid soluble polymer. H N Advantages of Self association NREP has high T g (121.2 ). This avoids tack during pharmaceutical processing like drying and heat sealing. No change in release pattern on curing. Rigid polymer structure inhibits adherence to biological membranes, enhances biocompatibility. The association of pyridine nitrogen inhibits its interactions with acidic drugs thereby avoiding the adverse drug-polymer interactions normally seen in acidic drugs and cationic polymers. Polyacid-polybase blends result in complexation and cannot be used for film coating applications. The self associations in NREP result in controlled hydrogen bonding with polyacids and other nonionic polymers. This provides a new set of miscible film forming blends of polyacids and NREP which can be used to custom sustained release of drugs. National he mical Laboratory, Pune India 2 National hemical Laboratory, Pune India 2

Pharmaceutical Applications 1) oatings for Immediate Release: 4) Alternative to the existing cationic NREP film coatings can be used for rapid release at gastric ph < 3. polymers. NREP is an ideal hydrophobic coating agent which offers rapid release in 2) Taste Masking Applications: NREP stomach. can be used for coating conventional, orally 5) oatings for Sustained Release: The disintegrating tablets and granules for blends of NREP with polyacids like Eudragit reconstitution, with rapid release in stomach and inhibition of drug release at salivary ph. L, Eudragit S, ellulose acetate phthalate, Hydroxy propyl methyl cellulose phthalate 3) Moisture Barrier oatings: NREP can be tailored to ensure sustained release of coatings provide moisture barriers for drugs along the entire length of GI tract. anhydrous drugs or drugs exhibiting polymorphic transformations in presence of moisture. NREP vs. ommercially Available ationic Polymer Properties Eudragit E NREP NREP Merits T g 45-50 121.2 No tack during storage and processing Storage Temperature ph Response Interactions With Drugs Interactions with other excipients 25 and below No Stringent requirements Soluble < ph 5 Permeable above ph 5.0 Interacts with acidic drugs Strong Interactions Polyelectrolyte complex formation Soluble < ph 3.5 Impermeable above ph 4.0 Inert to acidic drugs Weak Interactions No omplexation Film Forming ability Polymer and product performance not affected by storage and processing history Ideal for Taste Masking of Solid Dosage Forms and Liquid Orals, Granules for Reconstitution Rapid release at gastric ph More stable dosage forms Provides New Set of Film coatings for sustained release applications National hemical Laboratory, Pune India 3 National hemical Laboratory, Pune India 3

Taste Masking The highly bitter drugs efuroxime axetil, iprofloxacin HL and larithromycin were encapsulated by NREP coatings. NREP ensures immediate release in the gastric region by dissolution of polymer. Taste masking with immediate release of larithromycin is especially useful to treat H. Pylori infections in children. efuroxime axetil and iprofloxacin Hl is better absorbed from upper gastric region and hence rapid release in stomach is especially desirable to ensure bioavailability and NREP coating also provides taste masking. Further, NREP coatings can be used for other drugs to achieve taste masking and enhancing patient compliance. NREP dissolves rapidly at acidic ph ensuring immediate release of drug efuroxime axetil at gastric ph. ph 4.5 ph 5.8 NREP is impervious to moisture at salivary and reconstitution ph and inhibits drug release enhancing palatability. National hemical Laboratory, Pune India 4 National hemical Laboratory, Pune India 4

NREP Blends for Sustained Drug Release The self-associations in NREP result in controlled hydrogen bonding with anionic polymers. This provides a new set of miscible film forming blends of polyacids and polybase without complexation. NREP forms film forming blends with polyacids like ellulose acetate phthalate, hydroxyl propyl methyl cellulose phthalate, Eudragit L and Eudragit S. The blend compositions can be optimized to provide sustained gastric and intestinal release of drugs. Yet another advantage of using blends is that the amount of each component is reduced such that it falls within the permissible safe limits prescribed by FDA. 100 100 % Drug Release 80 60 40 20 0 0 50 100 150 200 250 Time in min NREP 0.2+ HPMP 0.3 NREP 0.2+ HPMP 0.2 NREP 0.3+HPMP 0.2+ EUD L0.2 NREP 0.3+ HPMP 0.05 % A release 80 60 40 20 0 0 50 100 150 200 250 Time in min F7 F8 F10 F11 NREP forms miscible blends with HPMP, AP, Ethylcellulose and Eudragit L useful to modulate drug release at acidic ph 100 100 80 80 % Release 60 40 % Release 60 40 20 20 0 0 1 2Time (hr) 3 4 5 50-50 : NREP-AP, 25:75 NREP-AP, 20:80 NREP-AP, 15:85 NREP-AP, 0 0 1 2 3 4 5 Time ( hr) 50:50 NREP-HPMP, 25:75 NREP-HPMP, 34:66 NREP:HPMP, 40:60 NREP-HPMP, Blends of NREP with HPMP and AP effectively sustain the release of highly water soluble drug at ph 1.2 and 5.8 National hemical Laboratory, Pune India 5 National hemical Laboratory, Pune India 5

NREP for Polymorphism Inhibition of Drugs Solid dispersions are used for enhancing dissolution of drugs. The residual solvent always induces devitrification of drugs. High Molecular Weight NREP inhibits conversion of metastable / amorphous form of polymorphic drug to stable crystalline form. The retention of amorphous form of polymorphic drugs enhances dissolution and bioavailability. NREP inhibits polymorphic transformations during formulation of solid dispersions Blends of NREP-Fatty Acids for Taste Masking NREP forms miscible blends with Fatty acids. Since Fatty acids are hydrophobic they are used to provide moisture protection and taste masking of granules for reconstitution. The major limitation of fatty acids is they result in slow release of drugs. The NREP-Fatty acid blend can be used for taste masking applications and as hydrophobic coatings with rapid release in stomach. These coatings can be applied by spray drying, hotmelt granulation and by wurster coating. National hemical Laboratory, Pune India 6 National hemical Laboratory, Pune India 6

Adaptability to Processing NREP is obtained as white odorless fine powder. NREP solutions can be prepared easily in most of the solvents used in pharmaceutical processing like methanol, ethanol, isopropanol, chloroform and methylene chloride. NREP forms clear and transparent films. NREP solutions can be used for film coating using the common coating equipments. It can withstand the heat during coating, drying and heat sealing process. NREP solutions can be spray dried easily. NREP is compatible with most of the pharmaceutical excipients. NREP haracteristics NREP can be synthesized in molecular weight ranges from 50 kd to 250 kd onwards for coating applications polymorphism inhibition. The T g of NREP is 121.2 (determined by MDS). Dissolution ph of NREP NREP film dissolves completely in the buffer ph 1.2 in 30-45 min but does not solubilize at ph 4.5 and 5.8. Figure shows equilibrium swelling at ph 4.5 and 5.8 and in distilled water. The dissolution characteristics of NREP make it ideal for the gastric delivery of drugs and for the formulation of taste-masked products, especially liquid oral preparations like dry syrup. Minimum swelling of NREP at different ph and water Moisture Barrier Properties NREP is insoluble in water. It is completely impervious to water and these impart moisture barrier/ sealant properties to film coatings of NREP. The SEM evaluation of NREP coatings exposed to water for seven days does not show any morphological changes in the film. The TGA analysis showed a total moisture uptake of less than 2% on immersion of film in water for seven days. However the coatings are soluble in gastric ph rapidly unlike the hydrophobic cellulosic polymers which effectively protect from moisture but cause delayed release. These properties can be exploited for National hemical Laboratory, Pune India 7 National hemical Laboratory, Pune India 7

providing moisture barrier during storage and yet ensuring rapid release in stomach. Moisture Barrier Properties of NREP films (No change on exposure to distilled water for 7 days). Biocompatibility of NREP In-vitro Biological Response The response of NREP extracts on mouse fibroblast cells is shown below. The morphological examination of cell cultures treated with 25, 50 and 100% NREP extract, showed that the L929 mouse fibroblast cells were confluent and showed discrete intracytoplasmic granules with no cell lysis. These results indicate NREP is noncytotoxic as per in-vitro biological reactivity tests (USP). In-vivo Biological Response NREP extract in sodium chloride injection and cottonseed oil was used for intravenous and intraperitoneal injection test respectively. None of the animals injected showed any abnormalities or loss in body weight during the observation period. The results showed that NREP extracts in both media meet the requirements of the systemic injection test for intravenous and intraperitoneal application as per USP. The in vitro and in vivo biological reactivity tests show that NREP is non toxic. Moisture Barrier Properties of NREP films (only 2% of water uptake on exposure of 7days). Response of mouse fibroblast cells to NREP extracts National hemical Laboratory, Pune India 8 National hemical Laboratory, Pune India 8

Selected References and Patents The detailed scientific understanding of the structure of NREP and its implications on properties and pharmaceutical applications can be found in following references. Miscible blends of Reverse Enteric Polymer with Enteric and ph independent Polymers: Mechanistic Investigations for Tailoring Drug Release, Biomacromolecules, 8, 240-251, 2007 Designing a Self Associated ationic Polymer for Enhanced ompatibility, Palatability and Gastric Release of efuroxime axetil Biomacromolecules, 8, 532-542, 2007 Mechanistic Investigations of Phase Behavior in Eudragit E Blends International Journal of Pharmaceutics (ASAP Articles) May 2007 US 20050137372, ph Sensitive Polymer And Process For Preparation Thereof US 20050136114, Taste Masked Pharmaceutical ompositions omprising Bitter Drug And ph Sensitive Polymer US 20050136115, Taste Masked Pharmaceutical omposition omprising ph Sensitive Polymer US 20050281874, oating ompositions For Bitterness Inhibition US 20060141053, Pharmaceutical omposition For Improving Palatability Drugs And Process For Preparation Thereof National hemical Laboratory, Pune India 9 National hemical Laboratory, Pune India 9

National hemical Laboratory Dr. Homi Bhabha Road Pashan Pune (411008) SIR-India For More Information Dr. M.G. Kulkarni Polymer Science & Engineering Division +91-20-25902178 +91-9422309762 Fax: + 91-20-25902618 mg.kulkarni@ncl.res.in www.ncl-india.org National hemical Laboratory, Pune India 10 National hemical Laboratory, Pune India 10